HomeCLRB • NASDAQ
add
Cellectar Biosciences Inc
Previous close
$0.31
Day range
$0.30 - $0.32
Year range
$0.22 - $3.51
Market cap
14.42M USD
Avg Volume
1.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.74M | 1.57% |
Net income | -2.36M | 70.11% |
Net profit margin | — | — |
Earnings per share | -0.01 | 97.50% |
EBITDA | -12.68M | -1.59% |
Effective tax rate | -2.88% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 23.29M | 143.48% |
Total assets | 25.47M | 110.96% |
Total liabilities | 9.80M | -62.10% |
Total equity | 15.68M | — |
Shares outstanding | 46.08M | — |
Price to book | 1.04 | — |
Return on assets | -101.52% | — |
Return on capital | -191.76% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.36M | 70.11% |
Cash from operations | -10.91M | -13.73% |
Cash from investing | -61.29K | 77.03% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -10.97M | -16.49% |
Free cash flow | -16.73M | -872.56% |
About
Founded
1996
Headquarters
Website
Employees
11
